RE: Nasdaq7 Jan 2025 20:43
My main concern with the nasdaq listing has been there would be no guarantee we could continue to hold the shares in an ISA.
At previous levels, we'd have had to list as an ADS listing, and when Verona Pharma did that, the shares had to be moved from ISA account into a standard holding account.
Hopefully the recent consolidation would mean that listing as ADS isn't necessary, so no issues with ISA holding.